Earnings History Data for Acrivon Therapeutics, Inc. (ACRV) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Acrivon Therapeutics, Inc.
Acrivon Therapeutics Inc. is a clinical stage biopharmaceutical company developing precision oncology medicines which matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing Acrivon's proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics. The company's lead candidate includes ACR-368. Acrivon Therapeutics Inc. is based in WATERTOWN, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-03-2024 | PM | ACRV | Acrivon Therapeutics, Inc. | 140.00 | -0.86 | -0.72 | 0.00 | Acrivon Therapeutics GAAP EPS of -$0.86 [3/28/2024 8:47 AM] |
7.13 | 0.67 (10.29%) |
0.0 | 0.0 (0.00%) |
3.19 - 14.39 | 64,831 | 100,000 | 0 | ||
| 09-11-2023 | PM | ACRV | Acrivon Therapeutics, Inc. | 127.00 | -0.66 | -0.72 | 0.00 | Acrivon Therapeutics GAAP EPS of -$0.66 beats by $0.04 [11/9/2023 11:51 AM] |
4.55 | -1.13 (-19.89%) |
5.40 | -0.28 (-4.93%) |
4.54 - 25.47 | 12,601 | 20,000 | 630 | ||
| 11-08-2023 | PM | ACRV | Acrivon Therapeutics, Inc. | 261.00 | -0.63 | -0.68 | 0.00 | Acrivon Therapeutics GAAP EPS of -$0.63 beats by $0.01 [8/11/2023 11:12 AM] |
12.39 | 0.79 (6.81%) |
0.0 | 0.0 (0.00%) |
8.06 - 25.47 | 16,758 | 10,000 | 0 | ||
| 09-05-2023 | PM | ACRV | Acrivon Therapeutics, Inc. | 275.00 | -0.58 | -0.64 | 0.00 | 13.01 | 0.30 (2.36%) |
0.0 | 0.0 (0.00%) |
8.06 - 25.47 | 18,064 | 20,000 | 0 | |||
| 28-03-2023 | PM | ACRV | Acrivon Therapeutics, Inc. | 272.00 | -0.80 | -1.10 | 0.00 | Acrivon Therapeutics GAAP EPS of -$0.80 beats by $0.58 [3/28/2023 9:38 AM] |
13.37 | -0.28 (-2.05%) |
0.0 | 0.0 (0.00%) |
10.90 - 25.47 | 11,966 | 270,000 | 0 | ||
| 15-12-2022 | AH | ACRV | Acrivon Therapeutics, Inc. | 263.00 | -5.17 | -2.44 | 0.00 | 12.39 | 0.87 (7.55%) |
0.0 | 0.0 (0.00%) |
10.90 - 20.70 | 8,909 | 10,000 | 0 | |||
|
|
||||||||||||||||||